BFSI
India Leads Global Shift to AI‑Led Healthcare Adoption, Says BCG Study
India has emerged as the world’s fastest‑adapting country when it comes to consumer‑facing AI‑assisted healthcare, with 85 per cent of Indian consumers already using AI‑driven tools for personal health management, according to a new study by Boston Consulting Group (BCG). The report, based on a survey of over 13,000 consumers across 15 countries, places India far ahead of key developed economies such as the...
NYC Hospital CEO Eyes AI Radiologist Replacement as Doctors Slam Tech Hype
The CEO of America's largest public hospital system has declared readiness to replace radiologists with AI for routine imaging reads like mammograms once regulations permit, igniting fierce backlash from physicians who accuse Nvidia's Jensen Huang and Anthropic's Dario Amodei of peddling "fiction" and "ignorance" to hype AI capabilities. Mitchell Katz, MD, president and CEO of NYC Health + Hospitals serving 1.1 million New Yorkers...
Eli Lilly Bets $2.75B on Insilico’s Pharma.AI Preclinical Pipeline
Eli Lilly and Company, the pharmaceutical giant behind diabetes blockbuster Mounjaro, has significantly expanded its artificial intelligence partnership with Insilico Medicine through a landmark licensing agreement potentially worth $2.75 billion. The deal grants Lilly exclusive worldwide rights to develop, manufacture, and commercialise multiple preclinical oral small-molecule drug candidates—entirely discovered by Insilico's Pharma.AI platform—representing one of the largest AI-driven drug discovery transactions to date. The agreement...
India-Uzbekistan Pharma Corridor Unlocks $10B CIS Market
India and Uzbekistan have launched a structured pharmaceutical and nutraceutical trade corridor in partnership with Uzbekistan’s Ministry of Health, Nutrify Today and Pharma Eurasia, positioning Tashkent as the gateway to the $7-10 billion CIS and broader Eurasian healthcare markets. The initiative combines regulatory harmonisation, investment facilitation and supply chain integration to streamline market entry for Indian manufacturers into 12 CIS nations and Central Asian...
Cohere Health GCC Scales Clinical AI from Hyderabad
US-based Cohere Health has launched a Global Capability Centre in Hyderabad, positioning India as a core element of its global operating model for AI-powered clinical intelligence solutions. The facility will evolve into a centre of excellence, integrating AI and machine learning engineering, analytics, clinical operations and product teams to enhance decision-making for health plans, clinicians and patients worldwide. By bridging clinical expertise with advanced...
NeuroDx MANAS‑1 Brain Model Targets Early Neurological Diagnosis
Deeptech startup NeuroDx has unveiled MANAS‑1, a 400‑million‑parameter brain foundation model that uses AI to decode human brain electrical activity and support early diagnosis of neurological disorders. The model was launched at the India AI Impact Summit and is among the first India‑built AI systems focused specifically on clinical‑grade brain health diagnostics. NeuroDx is one of 12 startups selected under the IndiaAI Mission, signalling...
Budget 2026: Department of Pharmaceuticals Allocation Hits ₹5,931 Crore
The Union Budget 2026 has increased the allocation for the Department of Pharmaceuticals to ₹5,931.22 crore, up from ₹5,268.72 crore in Budget 2025–26. The 12.6 percent increase places the department among the faster-growing allocations in the Union Budget. Within this total, the Production-Linked Incentive (PLI) scheme for pharmaceuticals has been allocated ₹2,445 crore in Budget Estimates for FY26–27. The allocation continues direct financial support...
Budget 2026: BioPharma SHAKTI Gets ₹10,000 Crore to Build India’s Biologics Manufacturing Hub
The Union Budget 2026 has announced BioPharma SHAKTI, a new national programme with an outlay of ₹10,000 crore over five years to strengthen India’s biologics and biosimilars manufacturing ecosystem.
The programme focuses on expanding domestic capability beyond conventional small-molecule generic medicines and building capacity in complex biological drugs. As part of the initiative, three new campuses of the National Institute of Pharmaceutical Education and Research...
Coforge Innovaccer G-Forge Accelerates Healthcare AI Scaling
Coforge and Innovaccer announced a strategic collaboration to drive AI-led modernization across healthcare ecosystems, launching G-Forge as a dedicated platform for scaling AI deployments. The partnership combines Coforge's enterprise transformation expertise with Innovaccer's Gravity AI infrastructure to deliver clinical, financial, and administrative improvements for providers, payers, life sciences, and healthtech firms. This initiative establishes Coforge as Innovaccer's preferred platinum implementation partner while creating a...
RightLife Launches Wearable-Free AI Preventive Healthcare Platform for India
RightLife, a JetSynthesys company with global reach across 180+ countries, has introduced India's first unified AI-driven preventive healthcare platform that operates entirely through smartphones, eliminating dependency on costly wearables. The platform addresses India's escalating lifestyle disease crisis—diabetes, hypertension, sleep disorders, chronic stress—where health awareness grows but preventive adoption remains constrained by fragmented apps, high hardware costs, and inconsistent behavior change. RightLife consolidates sleep, nutrition,...
News
ASML to Cut Around 1,700 Jobs in AI‑Driven Reorganisation
ASML, the Dutch semiconductor‑equipment giant that holds a near‑monopoly on advanced lithography tools used to manufacture cutting‑edge chips, is planning to cut roughly 1,700 jobs, or about 4 per cent of its 44,000‑person workforce. The move was announced in January alongside the company’s record full‑year revenue of €32.7 billion and signals a major internal reorganisation aimed at streamlining operations even as demand for advanced...